期刊文献+

β-羟基异戊酰紫草素对前列腺癌细胞株的生长抑制作用及机制研究 被引量:3

Growth inhibitory effect of β-hydroxyisovalerylshikonin on prostate cancer cells and related mechanism
下载PDF
导出
摘要 目的研究β-羟基异戊酰紫草素(β-HIVS)对激素非依赖性前列腺癌细胞株PC-3的体外生长抑制作用及其可能机制。方法采用MTT法检测β-HIVS对PC-3和人皮肤成纤维细胞株HSF的细胞生长抑制率;荧光素酶报告基因法检测给药后细胞中低氧诱导因子-1(HIF-1)和核因子κB(NF-κB)的转录活性;RT-PCR检测HIF-1下游靶基因血管内皮生长因子(VEGF)的表达;Westernblotting检测β-HIVS作用后HIF-1α蛋白的表达水平。结果β-HIVS对PC-3的细胞生长具有显著抑制作用(P<0.05),而对HSF的细胞生长无明显影响(P>0.05)。给药后PC-3细胞中NF-κB转录活性无明显变化(P>0.05);而HIF-1转录活性受抑(P<0.05),其下游靶基因VEGF表达下调,且细胞中HIF-1α蛋白累积减少。结论β-HIVS对PC-3的细胞生长具有抑制作用,其机制可能与β-HIVS减少低氧条件下PC-3中HIF-1α蛋白水平,抑制其转录活性,使下游促细胞生长靶基因VEGF表达下调有关。 Objective To investigate the growth inhibitory effects of β-hydroxyisovalerylshikonin(β-HIVS)on hormone-independent prostate cancer cell line PC-3,and explore the related mechanism.Methods The inhibition rates of β-HIVS on PC-3 cells and normal human skin fibroblasts(HSF)were determined by MTT method.Luciferase reporter assay was adopted to examine the transcriptional activity of hypoxia-inducible factor-1(HIF-1)and nuclear factor-kappa B(NF-κB).The expression of vascular endothelial growth factor(VEGF),the target gene of HIF-1,was detected by RT-PCR.The expression of HIF-1α protein in PC-3 cells treated by β-HIVS was detected by Western blotting.Results β-HIVS significantly inhibited the growth of PC-3 cells(P0.05),while had no significant effect on HSF cells(P0.05).There was no significant change in transcriptional activity of NF-κB in PC-3 cells after drug treatment(P0.05).β-HIVS inhibited the transcriptional activity of HIF-1 and decreased the expression of VEGF.The protein level of HIF-1α in PC-3 cells was reduced by β-HIVS.Conclusion β-HIVS inhibits the growth of PC-3 cells by decreasing the level of HIF-1α protein in PC-3 cells under hypoxia condition,thus attenuating the transcriptional activity of HIF-1α and decreasing the expression of VEGF.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2010年第5期527-530,共4页 Journal of Shanghai Jiao tong University:Medical Science
基金 上海市科委基础研究重点项目(08JC1413800)~~
关键词 β-羟基异戊酰紫草素 前列腺癌 低氧诱导因子-1 血管内皮生长因子 β-hydroxyisovalerylshikonin prostate cancer hypoxia-inducible factor-1 vascular endothelial growth factor
  • 相关文献

参考文献4

二级参考文献75

  • 1顾方六.Epidemiological survey of benign prostatic hyperplasia and prostatic cancer in China[J].Chinese Medical Journal,2000(4):11-14. 被引量:17
  • 2邵常霞,项永兵,刘振伟,高静,孙璐,方茹蓉,阮志贤,高立峰,金凡,高玉堂.上海市区泌尿系统恶性肿瘤相对生存率分析[J].中国肿瘤临床,2005,32(6):321-324. 被引量:31
  • 3Shen N, ed. Shen Nong Ben Cao Jing. Lanzhou: Lanzhou University Press, 2004.
  • 4Li SZ, ed. Ben Cao Gang Mu. Chongqing: Chongqing University Press, 1994.
  • 5Staniforth V, Wang SY, Shyur LF, et al. Shikonins, phytocompounds from Lithospermum erythrorhizon, inhibits the transcriptional activation of human tumor necrosis factor alpha promoter in vivo. J Biol Chem 2004; 279:5877-5885.
  • 6Shen CC, Syu JJ, Li YY, et al. Antimicrobial activities of naphthazarins from Arnebia euchroma. J Nat Prod 2002; 65:1857-1862.
  • 7Singh B, Sharma MK, Meghwal PR, et al. Anti-inflammatory activity of shikonin derivatives from Arnebia hispidissima. Phytomedicine 2003; 10:375-380.
  • 8Chen X, Oppenheim J, Howard OM. Shikonin, a component of anti-inflammatory Chinese herbal medicine, selectively blocks chemokine binding to CC chemokine receptor-l. Int Immunopharmaco12001 ; 1:229-236.
  • 9Sankawa U, Ebizuka Y, Miyazaki T, et al. Antitumor activity of shikonin and its derivatives. Chem Pharm Bull 1977; 25:2392-2395.
  • 10Sankawa U, Otsuka H, Kataoka Y, et al. Antitumor activity of shikonin, alkannin and their derivatives. II. X-ray analysis of cyclo-alkannin leucoacetate, tautomerism of alkannin and cyclo-alkannin and antitumor activity of alkannin derivatives. Chem Pharm Bull 1981; 29:116-122.

共引文献237

同被引文献36

  • 1吴振,吴立军,田代真一,小野寺敏,池岛乔.紫草素通过线粒体途径诱导A375-S2细胞凋亡[J].中国中药杂志,2004,29(12):1173-1177. 被引量:9
  • 2张雪莉,时彦,张圣明.β-羟基异戊酰紫草素对白血病细胞作用的研究近况[J].国外医学(中医中药分册),2005,27(3):152-154. 被引量:2
  • 3黄河,谢冰芬,朱孝峰,冯公侃,周军民,王一,吴海强,黄志纾,古练权,刘宗潮.紫草素衍生物SYUNZ-7的抗肿瘤作用及其机制的初步研究[J].癌症,2005,24(12):1453-1458. 被引量:26
  • 4方武,彭荣章,龙向阳,郑英俊.紫草素对膀胱癌细胞T24增殖和凋亡的影响及其机制研究[J].天津药学,2006,18(2):10-12. 被引量:10
  • 5Komi Y, Suzuki Y, Shimamura M, et al. Mechanism of inhibition of tumor angiogenesis by beta-hydroxyisovalerylshikonin. Cancer Sci, 2009, 100: 269-277.
  • 6Takai N, Ueda T, Nishida M, et al. Beta-hydroxyisovalerylshikonin has a profound anti-growth activity in human endometrial and ovarian cancer cells.Gynecol Oncol, 2008, 109:107-114.
  • 7Hashimoto S, Xu M, Masuda Y, et al. beta-hydroxyisovalerylshikonin inhibits the cell growth of various cancer cell lines and induces apoptosis in leukemia HL-60 cells through a mechanism different from those of Fas and etoposide. J Biochem, 1999, 125:17-23.
  • 8Masuda Y, Nishida A, Hori K, et al. Beta-bydroxyisovalerylshikonin induces apoptosis in human leukemia cells by inhibiting the activity of a polo-like kinase 1 (PLK1). Oncogene, 2003, 22: 1012-1023.
  • 9Masuda Y, Shima G, Aiuchi T, et al. Involvement of tumor necrosis factor receptor-associated protein 1 (TRAP1) in apoptosis induced by beta-hydroxyisovalerylshikonin. J BiolChem, 2004, 279: 42503- 42515.
  • 10Nishida M, Nasu K, Ueda T, et al. β -Hydroxyisovalerylshikonin induces apoptosis and Go/G1 cell-cycle arrest of endometriotic stromal cells: a preliminary in vitro study. Human Reproduction, 2006, 21: 2850-2856.

引证文献3

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部